While cancer-specific exon–exon junctions may indeed be a source of neoepitopes, their sharedness across individuals and occurrence in cancer-relevant loci (e.g. EGFR, MUC16) are suggestive of underlying but as-of-yet unexplored biology. This evidence concerns the gene EGFR and cancer.